CIK 2057060
GF FUND MANAGEMENT CO. LTD.
Institutional 13F holdings & portfolio
Holdings
643
Portfolio Value
$1M+
Latest Report
Dec 31, 2025
Report Periods
4
Holdings
13F filings as of Dec 31, 2025 · Showing 351–400 of 643
| Ticker | Company | Shares | Value | Type |
|---|---|---|---|---|
| GPCR | Structure Therapeutics Inc | 1K | $50K–$100K | SH |
| ALKS | Alkermes PLC | 3K | $50K–$100K | SH |
| VNO | Vornado Realty Trust | 3K | $50K–$100K | SH |
| ACAD | ACADIA Pharmaceuticals Inc | 3K | $50K–$100K | SH |
| SRRK | Scholar Rock Holding Corp | 2K | $50K–$100K | SH |
| INDV | Indivior PLC | 2K | $50K–$100K | SH |
| IMVT | Immunovant Inc | 3K | $50K–$100K | SH |
| KRG | Kite Realty Group Trust | 4K | $50K–$100K | SH |
| CRNX | Crinetics Pharmaceuticals Inc | 2K | $50K–$100K | SH |
| FOLD | Amicus Therapeutics Inc | 6K | $50K–$100K | SH |
| DLTR | Dollar Tree Inc | 700 | $50K–$100K | SH |
| ADMA | ADMA Biologics Inc | 5K | $50K–$100K | SH |
| APGE | Apogee Therapeutics Inc | 1K | $50K–$100K | SH |
| MIRM | Mirum Pharmaceuticals Inc | 1K | $50K–$100K | SH |
| NAMS | Newamsterdam Pharma Co NV | 2K | $50K–$100K | SH |
| AMRX | Amneal Pharmaceuticals Inc | 6K | $50K–$100K | SH |
| MAC | Macerich Co/The | 4K | $50K–$100K | SH |
| MRSH | Marsh & McLennan Cos Inc | 415 | $50K–$100K | SH |
| SBRA | Sabra Health Care REIT Inc | 4K | $50K–$100K | SH |
| ACLX | Arcellx Inc | 1K | $50K–$100K | SH |
| PECO | Phillips Edison & Co Inc | 2K | $50K–$100K | SH |
| LGND | Ligand Pharmaceuticals Inc | 386 | $50K–$100K | SH |
| CUZ | Cousins Properties Inc | 3K | $50K–$100K | SH |
| TERN | Terns Pharmaceuticals Inc | 2K | $50K–$100K | SH |
| ARQT | Arcutis Biotherapeutics Inc | 2K | $50K–$100K | SH |
| KRC | Kilroy Realty Corp | 2K | $50K–$100K | SH |
| TARS | Tarsus Pharmaceuticals Inc | 833 | $50K–$100K | SH |
| XENE | Xenon Pharmaceuticals Inc | 2K | $50K–$100K | SH |
| IRT | Independence Realty Trust Inc | 4K | $50K–$100K | SH |
| FUTU | Futu Holdings Ltd | 410 | $50K–$100K | SH |
| TVTX | Travere Therapeutics Inc | 2K | $50K–$100K | SH |
| CGON | CG oncology Inc | 2K | $50K–$100K | SH |
| GRAL | GRAIL Inc | 765 | $50K–$100K | SH |
| VCYT | Veracyte Inc | 2K | $50K–$100K | SH |
| VERA | Vera Therapeutics Inc | 1K | $50K–$100K | SH |
| EPR | EPR Properties | 1K | $50K–$100K | SH |
| SKT | Tanger Inc | 2K | $50K–$100K | SH |
| APLS | Apellis Pharmaceuticals Inc | 2K | $50K–$100K | SH |
| RSG | Republic Services Inc | 292 | $50K–$100K | SH |
| MRP | Millrose Properties Inc | 2K | $50K–$100K | SH |
| COLD | Americold Realty Trust Inc | 5K | $50K–$100K | SH |
| NHI | National Health Investors Inc | 787 | $50K–$100K | SH |
| IDYA | Ideaya Biosciences Inc | 2K | $50K–$100K | SH |
| IRON | Disc Medicine Inc | 742 | $50K–$100K | SH |
| SGML | Sigma Lithium Corp | 4K | $50K–$100K | SH |
| MLYS | Mineralys Therapeutics Inc | 2K | $50K–$100K | SH |
| SUPN | Supernus Pharmaceuticals Inc | 1K | $50K–$100K | SH |
| WVE | WaVe Life Sciences Ltd | 3K | $50K–$100K | SH |
| BEAM | Beam Therapeutics Inc | 2K | $50K–$100K | SH |
| DYN | Dyne Therapeutics Inc | 3K | $50K–$100K | SH |